Skip to content

PHAREECLO: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHAREECLO

BE 0884.648.809
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€4,214
2024 · €51,494-€47,280
Equity
€449,127
2024 · €444,913+€4,214
Cash
€162,203
2024 · €141,618+€20,585
Balance sheet total
€1.0m
2024 · €634,949+€400,812

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€344,526

    up €344,526 (+171.8%), from €200,590 to €545,116

    of which Land and buildings: +€192,365

  • Cash +€20,585

    up €20,585 (+14.5%), from €141,618 to €162,203

    mainly Debts after one year (+€382,905) and Depreciation (+€35,527)

  • Stocks and contracts +€14,074

    up €14,074 (+7.4%), from €190,886 to €204,960

  • Receivables within one year +€12,067

    up €12,067 (+35.4%), from €34,112 to €46,179

    of which Other amounts receivable: +€11,910

Equity and liabilities
  • Debts after one year +€382,905

    up €382,905 (+500.1%), from €76,563 to €459,469

  • Current portion of long-term debt +€31,460

    up €31,460 (+359.5%), from €8,750 to €40,210

  • Trade debts -€17,765

    down €17,765 (-18.8%), from €94,471 to €76,706

Income statement
  • Gross operating margin -€23,197

    down €23,197 (-18.7%), from €124,073 to €100,876

  • Depreciation +€19,404

    up €19,404 (+120.4%), from €16,122 to €35,527

  • Taxes -€15,479

    no longer reported in 2025 (was €15,479)

  • Financial charges +€11,062

    up €11,062 (+243.2%), from €4,549 to €15,612

  • Staff costs +€10,237

    up €10,237 (+46.1%), from €22,187 to €32,424

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €51,494
Gross operating margin -€23,197
Staff costs -€10,237
Depreciation -€19,404
Other operating charges +€6,062
Other operating items -€4,571
Financial income -€350
Financial charges -€11,062
Taxes +€15,479
Result 2025 €4,214

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€12,948
Investment -€380,833
Financing +€414,365
Cash 2024 €141,618
Net result for the year +€4,214
Depreciation +€35,527
Stocks and contracts -€14,074
Receivables within one year -€12,067
Deferred charges and accrued income -€8,779
Trade debts -€17,765
Tax, wage and social debts +€977
Other debts +€511
Accrued charges and deferred income -€1,490
Investment in fixed assets (net) -€380,833
Debts after one year +€382,905
Current portion of long-term debt +€31,460
Cash 2025 €162,203
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €634,949 €1,035,761 +€400,812 +63.1%
Fixed assets 21/28 €201,770 €547,076 +€345,306 +171.1%
Intangible fixed assets 21 €975 €1,755 +€780 +80.0%
Tangible fixed assets 22/27 €200,590 €545,116 +€344,526 +171.8%
Land and buildings 22 €158,486 €350,851 +€192,365 +121.4%
Plant, machinery and equipment 23 €29,464 €116,478 +€87,014 +295.3%
Furniture and vehicles 24 €12,640 €77,787 +€65,147 +515.4%
Financial fixed assets 28 €205 €205 = 0.0%
Current assets 29/58 €433,179 €488,685 +€55,506 +12.8%
Stocks and contracts in progress 3 €190,886 €204,960 +€14,074 +7.4%
Stocks 30/36 €190,886 €204,960 +€14,074 +7.4%
Amounts receivable within one year 40/41 €34,112 €46,179 +€12,067 +35.4%
Trade receivables 40 €16,129 €16,286 +€157 +1.0%
Other amounts receivable 41 €17,983 €29,893 +€11,910 +66.2%
Cash at bank and in hand 54/58 €141,618 €162,203 +€20,585 +14.5%
Deferred charges and accrued income 490/1 €66,563 €75,342 +€8,779 +13.2%
Total equity and liabilities 10/49 €634,949 €1,035,761 +€400,812 +63.1%
Equity 10/15 €444,913 €449,127 +€4,214 +0.9%
Contributions 10/11 €160,000 €160,000 = 0.0%
Reserves 13 €284,913 €289,127 +€4,214 +1.5%
Distributable reserves 133 €284,913 €289,127 +€4,214 +1.5%
Amounts payable 17/49 €190,036 €586,634 +€396,598 +208.7%
Amounts payable after more than one year 17 €76,563 €459,469 +€382,905 +500.1%
Financial debts 170/4 €76,563 €459,469 +€382,905 +500.1%
Amounts payable within one year 42/48 €109,683 €124,865 +€15,183 +13.8%
Current portion of amounts payable after more than one year 42 €8,750 €40,210 +€31,460 +359.5%
Trade debts 44 €94,471 €76,706 -€17,765 -18.8%
Suppliers 440/4 €94,471 €76,706 -€17,765 -18.8%
Taxes, remuneration and social security 45 €6,446 €7,422 +€977 +15.2%
Taxes 450/3 €448 €442 -€6 -1.2%
Remuneration and social security 454/9 €5,998 €6,980 +€982 +16.4%
Other amounts payable 47/48 €16 €527 +€511 +3196.8%
Accrued charges and deferred income 492/3 €3,790 €2,300 -€1,490 -39.3%
Remuneration, social security and pensions 62 €22,187 €32,424 +€10,237 +46.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €16,122 €35,527 +€19,404 +120.4%
Other operating charges 640/8 €15,292 €9,230 -€6,062 -39.6%
Non-recurring operating charges 66A - €4,571 +€4,571
Gross operating margin 9900 €124,073 €100,876 -€23,197 -18.7%
Operating profit (loss) 9901 €70,471 €19,124 -€51,347 -72.9%
Financial income 75/76B €1,051 €701 -€350 -33.3%
Recurring financial income 75 €1,051 €701 -€350 -33.3%
Financial charges 65/66B €4,549 €15,612 +€11,062 +243.2%
Recurring financial charges 65 €4,549 €15,612 +€11,062 +243.2%
Profit (loss) for the period before taxes 9903 €66,973 €4,214 -€62,760 -93.7%
Income taxes 67/77 €15,479 - -€15,479
Profit (loss) for the period 9904 €51,494 €4,214 -€47,280 -91.8%
Profit (loss) for the period to be appropriated 9905 €51,494 €4,214 -€47,280 -91.8%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.